PILERI, STEFANO
Dettaglio
PILERI, STEFANO
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
PILERI S; S. A. PILERI.; Pileri Stefano; Stefano A Pileri; Pileri, Stefano A.; Pileri, Stefano Aldo; PILERI SA; SA. Pilaeri.; S. Pileri; STEFANO PILERI; Pileri S.A.]; Pileri
Pubblicazioni
Risultati 1 - 20 di 368 (tempo di esecuzione: 0.002 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study. | M. Martelli;L. Ceriani;E. Zucca;P. L. Zinzani;A. J. M;U. Vitolo;C. Stelitano;E. Brusamolino;M. G.... Cabras;L. Rigacci;M. Balzarotti;F. Salvi;S. Montoto;A. Lopez-Guillermo;E. Finolezzi;S. A. Pileri;A. Davies;F. Cavalli;L. Giovanella;P. W. M | 2014 | JOURNAL OF CLINICAL ONCOLOGY | 1.01 Articolo in rivista | - | |
2 | A case of primary MALT lymphoma of the endometrium presenting as an asymptomatic polyp. | Annibali O; Romeo AA; Agostinelli C; Marchesi F; Natale A; De Muro M; Tirindelli MC; Pileri SA; A...vvisati G. | 2009 | ANNALS OF HEMATOLOGY | 1.01 Articolo in rivista | - | |
3 | A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF. | Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettiro...ssi V; Pileri SA; Nicoletti I; Falini B. | 2009 | LEUKEMIA | 1.01 Articolo in rivista | - | |
4 | A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathy. | Visentini M; Carbonari M; Ghia E; De Propriis S; Guarini A; Girmenia C; Giannini G; Sabattini E;... Ceccarini C; Zamarchi R; Giangaspero F; Novelli A; Amadori A; Pileri SA; Fiorilli M. | 2006 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | - | |
5 | A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma. | Döring C;Hansmann ML;Agostinelli C;Piccaluga PP;Facchetti F;Pileri S;Küppers R;Newrzela S;Hartmann S | 2014 | MODERN PATHOLOGY | 1.01 Articolo in rivista | - | |
6 | A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. | Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pe...llegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M. | 2008 | ANNALS OF ONCOLOGY | 1.01 Articolo in rivista | - | |
7 | A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012 | ANNALS OF ONCOLOGY | 1.01 Articolo in rivista | - | |
8 | A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. | Chanudet E; Ye H; Ferry J; Bacon CM; Adam P; Müller-Hermelink HK; Radford J; Pileri SA; Ichimura ...K; Collins VP; Hamoudi RA; Nicholson AG; Wotherspoon AC; Isaacson PG; Du MQ. | 2009 | JOURNAL OF PATHOLOGY | 1.01 Articolo in rivista | - | |
9 | Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma. | Tzankov A; Zimpfer A; Went P; Maurer R; Pileri SA; Geley S; Dirnhofer S. | 2005 | MODERN PATHOLOGY | 1.01 Articolo in rivista | - | |
10 | Aberrant promoter methylation of multiple genes thoughout the clinico-pathologic spectrum of B-cell neoplastia. | Rossi D.; Capello D.; Gloghini A.; Franceschetti S.; Paulli M.; Bhatia K.; Saglio G.; Vitolo U.; ...Pileri S.A.; Esteller M.; Carbone A.; Gaidano G. | 2004 | HAEMATOLOGICA | 1.01 Articolo in rivista | - | |
11 | Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. | Rossi D; Cerri M; Capello D; Deambrogi C; Berra E; Franceschetti S; Alabiso O; Gloghini A; Paulli... M; Carbone A; Pileri SA; Pasqualucci L; Gaidano G | 2005 | LEUKEMIA | 1.01 Articolo in rivista | - | |
12 | Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. | Liso A; Capello D; Marafioti T; Tiacci E; Cerri M; Distler V; Paulli M; Carbone A; Delsol G; Cam...po E; Pileri S; Pasqualucci L; Gaidano G; Falini B. | 2006 | BLOOD | 1.01 Articolo in rivista | - | |
13 | Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. | Curti A; Aluigi M; Pandolfi S; Ferri E; Isidori A; Salvestrini V; Durelli I; Horenstein AL; Fior...e F; Massaia M; Piccioli M; Pileri SA; Zavatto E; D'Addio A; Baccarani M; Lemoli RM. | 2007 | LEUKEMIA | 1.01 Articolo in rivista | - | |
14 | Acute renal failure in a young woman with Fisher-Evans’ syndrome. | De Sanctis B.A.; Mandrealo M.; Poggi C.; Pileri S.; Casanova S.; Santoro A. | 2004 | JN. JOURNAL OF NEPHROLOGY | 1.01 Articolo in rivista | - | |
15 | Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology. | Leoncini L; Delsol G; Gascoyne RD; Harris NL; Pileri SA; Piris MA; Stein H. | 2005 | HISTOPATHOLOGY | 1.01 Articolo in rivista | - | |
16 | Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. | Gallamini A.; Zaja F.; Patti C.; Billio A.; Specchia MR.; Tucci A.; Levis A.; Manna A.; Secondo V....; Rigacci L.; Pinto A.; Iannitto E.; Zoli V.; Torchio P.; Pileri S.; Tarella C. | 2007 | BLOOD | 1.01 Articolo in rivista | - | |
17 | ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK(+) ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project | Savage, KJ; Harris, NL; Vose, JM; Ullrich, F; Jaffe, ES; Connors, JM; Rimsza, L; Pileri, SA; Chha...nabhai, M; Gascoyne, RD; Armitage, JO; Weisenburger, DD; Zinzani, P | 2008 | BLOOD | 1.01 Articolo in rivista | - | |
18 | Alteration of BIRC3 and Multiple Other NF-{kappa}B Pathway Genes in Splenic Marginal Zone Lymphoma | D. Rossi ; S. Deaglio; D. Dominguez-Sola; S. Rasi; T. Vaisitti; C. Agostinelli; V. Spina; A. Brus...caggin; S. Monti; M. Cerri; S. Cresta; M. Fangazio; L. Arcaini; M. Lucioni; R. Marasca; C. Thieblemont; D. Capello; F. Facchetti; I. Kwee; S. A. Pileri; R. Foà; F. Bertoni; R. Dalla-Favera; L. Pasqualucci; G. Gaidano | 2011 | BLOOD | 4.02 Riassunto (Abstract) | - | |
19 | Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma | D. Rossi; S. Deraglio; D. Dominguez-Sola; S. Rasi; T. Vaisitti; C. Agostinelli; V. Spina; A. Brus...caggin; S. Cresta; S. Monti; M. Cerri; M. Fangazio; L. Arcaini; M. Paulli; R. Marasca; C. Thieblemont; D. Capello; F Facchetti; I. Kwee; S. Pileri; R. Foà; F. Bertini; R. Dalla-Favera; L. Pasqualucci; G. Gaidano. | 2011 | BLOOD | 1.01 Articolo in rivista | - | |
20 | The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin. | Ambrosio MR;Piccaluga PP;Ponzoni M;Rocca BJ;Malagnino V;Onorati M;De Falco G;Calbi V;Ogwang M;Nar...esh KN;Pileri SA;Doglioni C;Leoncini L;Lazzi S | 2012 | PLOS ONE | 1.01 Articolo in rivista |